Business UpdateApr 29, 2026, 08:11 AM
CTS Targets 10% Organic/Inorganic Growth; LTM Revenue $555M
AI Summary
CTS Corporation released an investor presentation outlining its strategy to achieve 10% organic and inorganic growth, driven by deep custom engineered capabilities and megatrend tailwinds. The company reported LTM revenue of $555 million as of March 2026, with 58% from diversified end markets including industrial, aerospace & defense, and medical. CTS aims for mid-single digit organic growth, supported by a strong balance sheet for M&A and a focus on technology and operational excellence.
Key Highlights
- Targeting 10% organic and inorganic growth.
- LTM Revenue $555 million as of March 2026.
- LTM Adjusted EBITDA Margin 23%; LTM Adjusted Diluted EPS $2.41.
- Diversified end markets (Industrial, Aerospace & Defense, Medical) comprise 58% of revenue.
- Medical market LTM revenue $90 million, up 25% YOY.
- Industrial market LTM revenue $145 million, up 14% YOY.
- Aerospace & Defense LTM revenue $85 million, up 15% YOY.